Thermablate EAS: a new endometrial ablation system

Abstract

Objective: To report on Thermablate EAS, the newest endometrial thermal balloon ablation system now available. Design: Thermablate EAS consists of a lightweight reusable hand-held treatment control unit (TCU) with a single use disposable catheter-balloon-cartridge system. Treatment time is <2.5 min. A 6.0-mm diameter catheter allows it to be used in an office or outpatient setting utilizing minimal anesthesia/analgesia. Results: Six-month follow-up data obtained under a Special Access Program for Health Canada in a series of 54 patients showed amenorrhea 20%, spotting 20%, hypomenorrhea 37%, eumenorrhea 16%, and persisting menorrhagia 6%. Conclusion: Thermablate EAS is the smallest, most portable, and simplest endometrial ablation presently available. High rates of clinical success and patient satisfaction combined with enthusiastic acceptance by clinicians of this compact device makes it a very attractive endometrial ablation system.